MOLINA ARTURO MD
SEC insider (Form 3/4/5 filer). CIK 0001398940. Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX). 27 reported Form 4/5 transactions since Sep 2024; latest on Mar 26, 2026. Located in NEWARK, CA.
Companies MOLINA ARTURO MD has filed insider reports for
- Protagonist Therapeutics, Inc (PTGX): Officer, Chief Medical Officer
MOLINA ARTURO MD
CIK: 0001398940
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Protagonist Therapeutics, Inc
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Mar 26, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect15K shares at avg. $8.04$121K - Mar 26, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect15K shares at avg. $104.79$1.6M - Jan 27, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect5K shares at avg. $82.00$410K - Jan 27, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect5K shares at avg. $8.04$40K - Jan 26, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect5K shares at avg. $82.28$411K - Jan 26, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect5K shares at avg. $8.04$40K - Jan 23, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect13.2K shares at avg. $82.42$1.1M - Jan 20, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect9.5K shares at avg. $82.48$785K - Jan 2, 2026PTGX
Protagonist Therapeutics, Inc
AwardDirect25.6K shares- - Nov 17, 2025PTGX
Protagonist Therapeutics, Inc
SaleDirect2.7K shares at avg. $84.77$230K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 15,000 | $8.04 | $120,600 | Direct |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 15,000 | $104.79 | $1,571,850 | Direct |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 5,000 | $82.00 | $410,000 | Direct |
| Jan 27, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 5,000 | $8.04 | $40,200 | Direct |
| Jan 26, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 5,000 | $82.28 | $411,400 | Direct |
| Jan 26, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 5,000 | $8.04 | $40,200 | Direct |
| Jan 23, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 13,151 | $82.42 | $1,083,905 | Direct |
| Jan 20, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 9,514 | $82.48 | $784,715 | Direct |
| Jan 2, 2026 | PTGX Protagonist Therapeutics, Inc | Award | 25,600 | - | $0 | Direct |
| Nov 17, 2025 | PTGX Protagonist Therapeutics, Inc | Sale | 2,712 | $84.77 | $229,896 | Direct |
1-10 of 27 transactions